Toxiqua specializes in assessing the potential risks posed by chemicals, agrochemicals, pharmaceuticals, pollutants, and other substances to human health and the environment. We utilize advanced methodologies and adhere to industry standards to deliver reliable results and actionable insights to our clients.
We have greater than 100 years combined experience within various settings such as CRO, Industry and Consultancy covering chemicals, agrochemicals, small molecular entities, and large molecules/biologicals.
Expertise across various areas, specifically developmental and reproductive toxicology, developmental neurotoxicity, endocrine disruption, carcinogenicity and general repeated dose toxicity including numerous administration routes and a variety of pre-clinical species;
Available services include:
Study monitoring and coordinating outsourced packages of work.
Representation at ECHA RAC, ECHA Biocide WG, Regulatory Authority meetings.
Classification and labelling technical positions and advocacy approaches.
CRO selection and recommendations.
Testing strategy development.
Data gap analysis.
OECD and IUCLID dossiers for PPP, BPR and REACH.
QSAR analysis, New Approach Methodologies and Read-Across approaches.
Regulatory questions and queries.
Company Details
- Employees
- 6
- Founded
- -
- Address
- 39 Foregate Street, Worcester,england,united Kingdom
- Industry
- Business Consulting And Services
- NAICS
-
Management, Scientific, and Technical Consulting ServicesManagement Consulting ServicesOther Scientific and Technical Consulting ServicesOther Management Consulting Services
- Website
- http://www.toxiqua.com
- Keywords
- Worcester.
- HQ
- Worcester, England
Toxiqua Questions
Toxiqua's website is http://www.toxiqua.com
Toxiqua's LinkedIn profile is https://uk.linkedin.com/company/toxiqua-ltd
Toxiqua has
6 employees.
View email and phone details for 6
employees at Toxiqua.
Toxiqua's industry is
Business Consulting and Services
Toxiqua's categories are Business Consulting and Services
Toxiqua's founding year is 2024
